Citius Pharmaceuticals, Inc. — Director's Dealing 2015

Nov 4, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2015-10-08-06:00

Reporting Person: Dutia Suren G (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$0.54	2025-10-08-06:00	Common Stock (400000)		Direct

Footnotes

F1: The option granted shall vest and become exercisable as follows: the option to purchase 40,000 shares of common stock of the Company (the "Common Stock") vested on October 8, 2015, and the balance of the option, or the option to purchase 360,000 shares of Common Stock shall vest in twelve (12) equal installments commencing on December 31, 2015, provided that the Reporting Person continues to serve as a member of the Company's Board of Directors as of those dates. The maximum number of shares of Common Stock subject to the grant shall be 400,000. The Option was issued pursuant to the Company's 2014 Stock Incentive Plan.